{
  "abstract": "Lung cancer remains the leading cause of cancer death worldwide. While prevention strategies such as tobacco control remain crucial, differences in survival outcomes between high-income countries suggest that access to effective treatment also plays a key role.1 These differences occur despite similar healthcare expenditure and universal coverage systems, indicating that structural, cultural and clinical factors influence lung cancer care delivery.",
  "authors": [
    {
      "affiliations": [
        "Centre for Cancer Sciences, University of Nottingham, Nottingham, England, UK"
      ],
      "name": "Emma L O’Dowd"
    },
    {
      "affiliations": [
        "Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, England, UK",
        "Leeds Institute of Health Sciences, University of Leeds, Leeds, England, UK"
      ],
      "name": "Matthew EJ Callister"
    }
  ],
  "title": "Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy use",
  "uid": "3a8a8678-1019-52f6-aed4-332395b76f28"
}